Executive Overview
Lumbar disc herniation (LDH) remains one of the most debilitating and widespread spinal musculoskeletal disorders globally, affecting an estimated 2% to 3% of the world’s population. Characterized by the disruption of the annulus fibrosus and the subsequent displacement of the nucleus pulposus—leading to severe nerve ischemia, chemical inflammation, excruciating lower back pain, and radiating lower extremity symptoms—LDH places an immense burden on modern healthcare systems. Beyond the physical toll of chronic pain, patients face a heightened risk of undergoing invasive spinal surgeries and falling victim to long-term dependency on opioid analgesics.
In response to these public health challenges, a comprehensive, nationwide, population-based retrospective cohort study published in Frontiers in Public Health has evaluated the real-world impact of early conservative intervention. Researchers investigated whether early Korean medicine (KM) treatments—such as acupuncture, cupping, and other integrative modalities—can alter the clinical trajectory of newly diagnosed LDH patients. Analyzing massive health insurance claims data from South Korea’s Health Insurance Review and Assessment Service (HIRA), the research team uncovered striking evidence: patients who received early KM interventions demonstrated a statistically significant reduction in both the risk of undergoing subsequent lumbar surgery and the likelihood of receiving opioid analgesic prescriptions over a rigorous four-year follow-up period.
Detailed Chronology & Methodology
The foundational data for this nationwide investigation were drawn from South Korea’s National Health Insurance (NHI) system, which provides universal health coverage to approximately 97.1% of the country’s population, thereby eliminating selection biases common in smaller regional studies.
Defining the Patient Cohort
The research team tracked healthcare utilization records from January 1, 2014, to December 31, 2020. The primary study population comprised individuals newly diagnosed with lumbar and other intervertebral disc disorders featuring radiculopathy (ICD-10: M51.1) between January 1 and December 31, 2015. Out of an initial pool of 1,390,733 diagnosed individuals, 788,505 patients met the strict eligibility criteria.
To account for the complex structural pathology and clinical severity of imaging-confirmed LDH, researchers established an entry date at the first diagnosis in 2015 and a distinct index date set 60 days later. This 60-day exposure window allowed clinicians sufficient time to map the primary treatment trajectory of each patient. Patients with "red flag" conditions (such as malignancies, major trauma, or infections), a prior history of lumbar surgery, or pre-existing opioid prescriptions were systematically excluded.
Propensity Score Matching (PSM)
To minimize confounding and selection bias, the researchers executed a 1:1 propensity score matching model based on key demographic and clinical variables, including sex, age group, insurance type, and the Charlson Comorbidity Index (CCI). This rigorous process yielded two distinct analytical datasets:
- The Surgery Dataset: Comprising 121,720 matched patients equally divided between the KM group ($n = 60,860$) and the conventional medicine (CM) group ($n = 60,860$).
- The Opioid Dataset: Comprising 72,684 matched patients equally divided between the KM group ($n = 36,342$) and the CM group ($n = 36,342$).
Patients were categorized into the KM group if they completed three or more outpatient visits to Korean medicine institutions within the 60-day window (exceeding their conventional medicine visits), while the CM group consisted of patients with three or more conventional outpatient visits without KM utilization.
Supporting Context & Key Metrics
Following the creation of the matched cohorts, researchers applied Kaplan-Meier survival curves, log-rank tests, and Cox proportional hazards regression models—incorporating sequential covariate adjustments—to measure outcomes across a four-year window.
Lumbar Surgery Outcomes
Over the four-year follow-up, 3,362 patients (5.52%) in the KM group underwent lumbar surgery, compared to 3,669 patients (6.03%) in the CM group. This yielded an absolute risk difference of 0.51 percentage points and a number needed to treat (NNT) of 196.
Because the proportional hazards assumption varied over time, time-stratified hazard ratios (HRs) were evaluated:
- At 1-Year Follow-Up: The fully adjusted hazard ratio for lumbar surgery in the KM group was 0.715 (95% CI, 0.665–0.769), representing a substantial 28.5% relative reduction in the hazard of surgery.
- At 4-Year Follow-Up: The hazard ratio stood at 0.801 (95% CI, 0.762–0.842), indicating a sustained 19.9% relative hazard reduction.
Opioid Analgesic Prescriptions
Given the global public health crisis surrounding opioid overprescription and addiction, researchers also tracked the incidence of opioid prescriptions (defined as $ge 7$ days for non-tramadol opioids or $ge 14$ days for tramadol).
- During the four-year tracking period, 2,957 patients (8.14%) in the KM group received qualifying opioid prescriptions compared to 3,103 patients (8.54%) in the CM group.
- The fully adjusted Cox proportional hazards model revealed a hazard ratio of 0.891 (95% CI, 0.844–0.940), translating to a statistically significant 10.9% relative reduction in the risk of opioid prescriptions for LDH-related pain.
- When evaluating non-tramadol opioids specifically, early KM intervention was associated with an even more pronounced relative hazard reduction of 17.7% (HR 0.823; 95% CI, 0.721–0.939).
| Outcome Measure | Follow-Up Period | Adjusted Hazard Ratio (HR) | 95% Confidence Interval | Relative Risk Reduction |
|---|---|---|---|---|
| Lumbar Surgery | 1 Year | 0.715 | 0.665 – 0.769 | 28.5% |
| Lumbar Surgery | 4 Years | 0.801 | 0.762 – 0.842 | 19.9% |
| Opioid Prescription | 4 Years | 0.891 | 0.844 – 0.940 | 10.9% |
| Non-Tramadol Opioids | 4 Years | 0.823 | 0.721 – 0.939 | 17.7% |
Official Statements & Expert Analysis
The study’s authors emphasize that while the absolute risk differences appear modest on paper, they carry immense clinical relevance when viewed within the natural history of LDH. Most patients suffering from lumbar disc herniation recover with conservative care, yielding a naturally low baseline surgical rate (reflected by the 6.03% four-year surgery rate in the conventional medicine group).
"In this setting, relative hazard reductions of approximately 20% for surgery and roughly 11% for opioid prescriptions represent meaningful clinical effects concentrated among patients who would otherwise progress to invasive surgical interventions or long-term pharmaceutical dependency," the authors noted.
Experts point out that the time-varying nature of the surgery hazard reduction—stronger at one year than at four years—suggests that early KM intervention primarily delays or successfully manages the acute-to-subacute phase of pathology. This temporal window is critical, as avoiding early surgery or heavy pharmaceutical intervention prevents patients from incurring immediate postoperative complications, reoperation risks, and drug dependency.
Furthermore, the robustness of these findings was confirmed through E-value sensitivity analyses. The E-value for lumbar surgery stood at 1.804, while the E-value for opioid prescriptions was 1.492. These metrics indicate that an unmeasured confounder would need an exceptionally strong association with both KM treatment and the clinical outcomes to completely nullify the observed protective effects.
Future Outlook & Policy Implications
The implications of this nationwide cohort study extend far beyond individual patient care, offering a roadmap for healthcare administrators and policy architects grappling with escalating spinal care expenditures and opioid management crises.
As healthcare systems worldwide search for safe, non-pharmacological alternatives to manage musculoskeletal disorders, the integration of traditional and conventional medicine—often termed integrative medicine—gains robust empirical backing from population-scale data. By demonstrating that early, structured non-pharmacological therapies can safely reduce surgical rates and curb opioid reliance, this research encourages health authorities to reconsider reimbursement frameworks and clinical guidelines.
Next Steps for Clinical Research
While the current retrospective cohort study successfully leverages universal claims data to establish real-world associations, the authors acknowledge certain limitations. Administrative claims databases lack granular clinical data regarding exact disc herniation dimensions, precise pain intensity scales, and neurological examination findings.
To build upon these foundational findings, future investigations must combine large-scale HIRA claims records with institutional electronic medical records (EMRs) and prospective randomized controlled trials. Such initiatives will help isolate the specific contributions of individual KM modalities (such as acupuncture versus pharmacopuncture or herbal medicines) and refine stepped-care clinical pathways for patients newly diagnosed with lumbar disc herniation across diverse global healthcare environments.